Eli Lilly and Novo Nordisk: The Battle for Dominance in the 2026 Weight-Loss Drug Market Jan 13, 2026 Life Science
A Trump Tariff Victory? U.S. Trade Gap Nosedives, But Economists See a Mirage Jan 8, 2026 Life Science, Precious Metals
Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion, Expanding Inflammation Portfolio Jan 7, 2026 Life Science
Looking Beyond Novo Nordisk, High-Yield Pfizer Is a Bigger Contrarian Opportunity Dec 22, 2025 Life Science
Backed by Nvidia, Recursion Soars 11% Following Bullish Analyst Call and Clinical Trial Update Dec 17, 2025 Life Science, Technology
